Vaccines List

AADvac1 Alzheimer's Disease Vaccine

AADvac1 is a candidate therapeutic vaccine for Alzheimer's disease that targets misfolded tau protein, a common denominator of neurofibrillary pathologyRead more...

ACAM2000 Smallpox Vaccine

ACAM2000 is a live vaccinia virus to protect against smallpox disease.Read more...

Actemra (Tocilizumab)

Actemra is an Interleukin-6 (IL-6) receptor antagonist approved by the FDA in 2010.Read more...

Ad26.COV2-S SARS-CoV-2 Vaccine

Ad26.COV2-S SARS-CoV-2 Vaccine candidate is progressing into a Phase 1/2a human clinical trial.Read more...

Ad26.Mos4.HIV HIV Vaccine

Ad26.Mos4.HIV is a tetravalent vaccine candidate containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts.Read more...

Ad5-GUCY2C-PADRE Colon Cancer Vaccine

Ad5-GUCY2C-PADRE is a replication-deficient human type 5 recombinant adenovirus (Ad5) vaccine encoding guanylyl cyclase C (GUCY2C) fused to the PAn DR Epitope (PADRE). Read more...

Ad5-nCoV COVID-19 Vaccine

Ad5-nCoV is a genetically engineered vaccine candidate with the replication-defective adenovirus type 5 as the vector to express SARS-CoV-2 spike protein.Read more...

Adacel Vaccine

Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Read more...

Afluria Quadrivalent Influenza Vaccine

Afluria Quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B.Read more...

AGI-134 Cancer Immunotherapy Vaccine

AGI-134 is a synthetic molecule that by intratumoral injection triggers a systemic anti-tumor response.Read more...

AnGes Coronavirus Vaccine

AnGes Coronavirus vaccine candidate is a plasmid DNA vaccine that disables the connection between the protein spikes of the coronavirus and receptors in human cells.Read more...

ASP3772 Pneumococcal Vaccine

ASP3772 utilizes the Multiple Antigen Presenting System (MAPS) platform which is Affinivax’s proprietary, next-generation vaccine technology. MAPS uniquely presents key epitopes of the desired antigens (polysaccharides and/or proteins) to induce a robust and broad immune response against challenging diseases.Read more...

ATX-GD-59 Graves' Disease Vaccine

ATX-GD-59 is a candidate for potential treatment to target the immunological basis of Graves' disease.Read more...

AV7909 Anthrax Vaccine

AV7909 is a combination of BioThrax (also called anthrax vaccine, adsorbed or AVA), an FDA-licensed vaccine, and CPG 7909.Read more...

Avigan Antiviral Medication

Avigan (favipiravir) is an antiviral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses.Read more...

Aviptadil (RLF-100) COVID-19 Therapeutic

Aviptadil is a formulation of synthetic human Vasoactive Intestinal Peptide (VIP).Read more...

AZD1222 SARS-CoV-2 Vaccine

AZD1222 SARS-CoV-2 vaccine candidate consists of the replication-deficient simian adenovirus vector ChAdOx1, containing the genetic sequence of the SARS-CoV-2 Spike protein.Read more...

Bacille Calmette-Guerin (BCG) Tuberculosis Vaccine

Bacille Calmette-Guerin (BCG) vaccine is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis.Read more...

BBV87 Chikungunya Vaccine

Bharat Biotech BBV87 vaccine candidate is an inactivated whole virion vaccine based on a strain derived from an East, Central, South African (ECSA) genotype.Read more...

Bexsero Meningitis B Vaccine

Bexsero contains different proteins taken from group B Neisseria meningitidis bacteria. The combination of proteins was chosen to protect against the majority of MenB strains. They are also expected to protect against other types of meningococcal bacteria, including MenW.Read more...

BG505 SOSIP.664 gp140 HIV Vaccine

BG505 SOSIP.664 gp140 is a stable, soluble, cleaved HIV envelope trimer. Read more...

BioThrax Anthrax Vaccine

BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...

BNT162 SARS-CoV-2 Vaccine

BNT162 is a vaccine candidate that will be used to prevent SARS-CoV-2 coronavirus infections which cause COVID-19 disease.Read more...

Boostrix Vaccine

Boostrix vaccine is used to help prevent tetanus, diphtheria, and pertussis in people who are at least 10 years old. Most people in this age group require only one Tdap shot for protection against these diseases.Read more...

BPZE1 Pertusiss Vaccine

BPZE1 is an intranasal vaccine candidate that consists of a live, attenuated form of the pertussis bacterium.Read more...

Cecolin HPV Vaccine

Cecolin HPV Vaccine protects women against HPV 16 and 18, two major HPV types causing 70 percent of all cervical cancers, the third most common cancer among women.Read more...

Cervarix HPV Vaccine

Cervarix vaccine is a non-infectious recombinant, AS04-adjuvanted vaccine, that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. Read more...

ChAdOx1 MERS Coronavirus Vaccine

ChAdOx1 MERS is a vaccine candidate to treat MERS coronavirus.Read more...

CHIKV-VLP Chikungunya Vaccine

Chikungunya Virus virus-like particle (CHIKV-VLP) vaccines are multi-protein structures that mimic the organization and conformation of naturally occurring viruses, without the viral genome, that could potentially promote a stronger immune response and increased antibody production.Read more...

Chirorab Rabies Vaccine

Chirorab is an inactivated rabies virus of the strain Flury LEP.Read more...

CoronaVac SARS-CoV-2 Vaccine

CoronaVac SARS-CoV-2 Vaccine candidate is based on an inactivated pathogen.Read more...

Covaxin SARS-CoV-2 Vaccine

Covaxin is an inactivated SARS-CoV-2 Vaccine candidate. The SARS-CoV-2 virus strain was isolated from an asymptomatic COVID-19 patient at NIV, Pune.Read more...

CRV 101 Shingles Vaccine

CRV-101 is a next-generation vaccine designed to maximize the CMI protection by combining the gE protein antigen with our proprietary adjuvantRead more...

CTH522 Chlamydia Vaccine

CTH522 is a Chlamydia vaccine candidate adjuvanted with CAF01 liposomes or aluminium hydroxide.Read more...

CVD 1208S-122 Diarrhea Vaccine

CVD 1208S-122 is a diarrhea vaccine candidate comprised of a weakened live strain of Shigella expressing protective antigens from ETEC 

 Read more...

CVnCoV SARS-CoV-2 Vaccine

CVnCoV is an mRNA vaccine candidate that utilizes nucleotides without chemical modifications in the mRNA.Read more...

Daptacel Vaccine

Daptacel is a combination vaccine that helps prevent diphtheria, tetanus, and pertussis. Diphtheria, tetanus, and pertussis are serious diseases caused by bacteriaRead more...

Delta gD-2 Herpes Vaccine

Delta gD-2 is a vaccine candidate based on an HSV-2 virus genetically deleted for glycoprotein D (gD-2). Read more...

Dengvaxia Dengue Vaccine

Dengvaxia is a vaccine that prevents dengue infection due to dengue virus serotypes 1, 2, 3, and 4.Read more...

Dexamethasone

Dexamethasone is a corticosteroid that reduces inflammation in a range of conditions, including inflammatory disorders and certain cancers. Read more...

DS-Cav1 RSV Vaccine

DS-Cav1 is an RSV vaccine candidate based on a structure-based design that has been used to generate an RSV fusion glycoprotein stabilized in its prefusion conformation.Read more...

Encepur Tick-Borne Encephalitis Vaccine

Encepur is a vaccine that consists of an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strainRead more...

Engerix-B Hepatitis B Vaccine

Engerix-B a Hepatitis B Vaccine is a noninfectious recombinant DNA hepatitis B vaccine.Read more...

ERVEBO Ebola Vaccine

ERVEBO (VSV-EBOV) is a recombinant, replication-competent Ebola vaccine, consisting of a vesicular stomatitis virus (VSV), which has been genetically engineered to express a glycoprotein from the Zaire ebolavirus so as to provoke a neutralizing immune response to the Ebola virus.Read more...

EXD-12 Herpes Simplex Vaccine

EXD-12 is a live attenuated vaccine candidate being researched and developed to prevent and treat the Herpes Simplex Virus.Read more...

Flu-v Influenza Vaccine

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza.Read more...

Fluad Influenza Vaccine

Fluad consists of an inactivated, trivalent influenza virus antigen produced in eggs and an oil-in-water emulsion adjuvant, MF59C.1.Read more...

Fluad Quadrivalent Influenza Vaccine

Fluad is a quadrivalent inactivated flu vaccine with an adjuvant designed specifically for people 65 years and older.Read more...

Fluarix Quadrivalent Influenza Vaccine

Fluarix Quadrivalent is prepared from influenza viruses propagated in embryonated chicken eggs. Each of the influenza viruses is produced and purified separately. Read more...

Flucelvax Quadrivalent Influenza Vaccine

Flucelvax Quadrivalent is a cell culture-based flu vaccine to help offer protection against 4 flu virus strains identified for the current flu season.Read more...

Flulaval Quadrivalent Influenza Vaccine

Flulaval Quadrivalent is a quadrivalent, split-virion, inactivated influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs.Read more...

FluMist Quadrivalent Influenza Vaccine

FluMist Quadrivalent is an Intranasal vaccine that is a live quadrivalent vaccine that is formulated to contain four vaccine virus strains.Read more...

Fluvirin Influenza Vaccine

Fluvirin is a live, attenuated or inactive virus, pathogen or toxoid of the identified flu strains for the particular flu season.Read more...

Fluzone Influenza Vaccines

Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Gam-COVID-Vac Vaccine

The Russian COVID-19 vaccine Gam-COVID-Vac uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.Read more...

Gardasil HPV Vaccine

Gardasil vaccine consists of 4 proteins of HPV types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...

Gardasil 9 HPV Vaccine

Gardasil 9 consists of HPV proteins, Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, Polysorbate 80, sodium borate, and water for injection.Read more...

GBS6 Group B Streptococcus Vaccine

GBS6 is a multivalent group B streptococcus vaccine candidateRead more...

Gen-003 Genital Herpes (HSV2) Vaccine

GEN-003 is an experimental immunotherapy vaccine comprised of 2 HSV-2 proteins, glycoprotein D2 and ICP4.2, and Matrix-M2 adjuvant (M2).Read more...

GEN-009 Cancer Vaccine

GEN-009 is an investigational, personalized adjuvanted vaccine, that is being developed for the treatment of patients with solid tumors.Read more...

GEO-CM01 SARS-CoV-2 Vaccine

GEO-CM01 vaccine candidate is based upon a novel platform that integrates our recombinant Modified Vaccinia Ankara (MVA) vector technology with advanced antigen design and state-of-the-art manufacturing technologies.Read more...

GEO-LM01 Lassa Fever Vaccine

GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinatedRead more...

GI.1/GII.4 Norovirus Vaccine

GI.1/GII.4 is a tablet oral norovirus vaccine consisting of both Monovalent GII.4 VXA-G2.4-NS and Monovalent GI.1 VXA-G1.1-NN.  Read more...

GLS-5300 MERS-CoV Vaccine

GLS-5300 is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein.Read more...

GOVX-B11 HIV Vaccine

GOVX-B11 is a vaccine candidate that uses recombinant DNA and recombinant modified vaccinia Ankara (MVA) vaccines to express non-infectious virus-like particles. Read more...

Havrix Hepatitis A Vaccine

Havrix is a sterile suspension of inactivated virus strain HM175 which is propagated in MRC-5 human diploid cells. After removal of the cell culture medium, the cells are lysed to form a suspension. This suspension is purified through ultrafiltration and gel permeation chromatography procedures. Treatment of this lysate with formalin ensures viral inactivation.Read more...

HBA120 Hepatitis B Vaccine

HBAI20 vaccine candidate consists of a standard HBV vaccine to which the AI20 adjuvant is added.

The adjuvant is able to give an additional stimulus to the immune system and... Read more...

Hecolin Hepatitis E Vaccine

Hecolin is a recombinant vaccine which contains the hepatitis E virus (HEV)-like particles prepared using a recombinant Escherichia coli expression systemRead more...

Heplisav-B Hepatitis B Vaccine

Heplisav-B combines hepatitis B surface antigen with Dynavax's proprietary Toll-like Receptor (TLR), 9 agonist, to enhance the immune response.Read more...

HER-Vaxx Cancer Vaccine

HER-Vaxx (IMU-131) is a B-cell peptide immunotherapy cancer vaccine candidate which is constructed from several B cell epitopes derived from the extracellular domain of HER-2/neu. Read more...

Herpes Vaccine Candidates

Herpes simplex virus (HSV) vaccine development has been an ongoing challenge for decades.Read more...

HSV529 Herpes Vaccine

HSV529 is a herpes vaccine candidate that is classified as a replication-defective virus, where the virus possesses all the components of the wild-type HSV virus with the exception of two proteins UL5 and UL29 that are involved in viral DNA replication. This replication-defective HSV2 vaccine candidate can infect cells and should result in a broader immune response.Read more...

HydroVax-001 West Nile Vaccine

HydroVax-001 is a vaccine candidate which consists of a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) adjuvanted with aluminum hydroxide.Read more...

ImmuneFx Cancer Therapeutic Vaccine

ImmuneFx is a therapeutic vaccine candidate which expresses a bacterial antigen on the surface of a patient’s own tumor cells. IFx primes and educates the immune system to destroy tumor cells throughout the body without harming healthy cells and tissues.Read more...

Imovax Rabies Vaccine

Imovax Rabies is an inactivated vaccine made from an attenuated rabies virus. It is a sterile, stable, freeze-dried suspension of Rabies Vaccine Inactivated virus prepared from WISTAR Rabies PM/WI 38 1503-3M strain.Read more...

Infanrix Vaccine

Infanrix is a vaccine indicated for immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks.Read more...

Influenza Vaccines

Influenza vaccines, known as flu shots, protect people against the influenza viruses that research indicates will be most common during the upcoming season. Read more...

INO-3107 Recurrent Respiratory Papillomatosis (RRP)

INO-3107 is a DNA medicine being evaluated for the treatment of recurrent respiratory papillomatosis.Read more...

INO-4500 Lassa Fever Vaccine

INO-4500 is a DNA-encoded monoclonal antibody (dMAb™) immunotherapy vaccine candidate.Read more...

INO-4700 MERS-CoV Vaccine

INO-470 is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein.Read more...

INO-4800 DNA Coronavirus Vaccine

INO-4800 is a DNA vaccine candidate matched to the SARS-CoV-2 CoronavirusRead more...

INO-A002 Zika Vaccine

INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) technology candidate.Read more...

IVX-121 Respiratory Syncytial Virus (RSV) Vaccine

IVX-121 an RSV vaccine candidate incorporates a stabilized prefusion F antigen licensed from NIAID/NIHRead more...

Ixiaro Japanese Encephalitis Vaccine

Ixiaro is an inactivated, adsorbed Vero cell culture-derived vaccine. It is prepared by propagating JEV strain SA14-14-2 in Vero cells.Read more...

Japanese Encephalitis Vaccines

Japanese encephalitis virus (JEV) is a flavivirus that is the main cause of viral encephalitis in many countries of Asia with an estimated 68,000 clinical cases every year.Read more...

Jenvac Japanese Encephalitis Vaccine

JENVAC is an inactivated vero cell-derived vaccine prepared from an Indian Kolar strain of the Japanese encephalitis virus.Read more...

JYNNEOS Smallpox Vaccine

JYNNEOS smallpox vaccine is based on a live, attenuated vaccinia virus (Modified Vaccinia Ankara, MVA-BN), incapable of replicating in the body, yet still capable of eliciting a potent immune response.Read more...

Kinrix PolioVirus Vaccine

Kinrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria as well as Inactivated Poliovirus Vaccine.Read more...

Leronlimab (PRO 140)

Leronlimab (PRO 140) is a drug candidate that is a CCR5 antagonist with the potential for multiple therapeutic indications.Read more...

LY-CoV555 COVID-19 Treatment

LY-CoV555 is a potent, neutralizing IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2.Read more...

M-001 Influenza Vaccine

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

M-M-R II Vaccine

M-M-R II vaccine is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus vaccine.Read more...

M72/AS01E Tuberculosis Vaccine

M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline proprietary adjuvant AS01E.Read more...

mAb114 Ebola Therapeutic Vaccine

mAb114 is a human IgG1 MAb targeted to the Zaire ebolavirus (EBOV) glycoprotein (GP).  mAb114 is a single monoclonal antibody which binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cellsRead more...

MenABCWY Meningococcal Vaccine

MenABCWY Meningococcal Vaccine Description

Pfizer’s pentavalent meningococcal vaccine candidate combines its two approved meningococcal vaccines, Nimenrix™ (meningococcal group A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B... Read more...

Menactra Meningococcal Vaccine

Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein. N meningitidis A, C, Y, and W-135 strains are cultured on Mueller Hinton agar and 10 grown in Watson Scherp media containing casamino acid.Read more...

Menveo Meningococcal Vaccine

Menveo consists of two portions: 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197 and 5 μg each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate-buffered saline, which is used to reconstitute the lyophilized MenA component.Read more...

Metablok LSALT Peptide

Metablok is a novel peptide drug candidate for treating inflammation in the lungs, liver, and kidneys. Read more...

Mosquirix Malaria Vaccine

Mosquirix (RTS,S/AS01) is a recombinant vaccine candidate consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.Read more...

mRNA-1273 SARS-CoV-2 Vaccine

mRNA-1273 is an mRNA vaccine candidate targeting the novel coronavirus SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein.Read more...

mRNA-1647 Cytomegalovirus Vaccine

mRNA-1647 is a vaccine candidate combining 6 mRNAs in a single vial, which encode for two antigens on the surface of cytomegalovirus (CMV): five mRNAs encoding the subunits that form the membrane-bound pentamer complex and one mRNA encoding the full-length membrane-bound glycoprotein B (gB).Read more...

mRNA-1653 hMPV+PIV3 Vaccine

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

mRNA-1893 Zika Vaccine

mRNA-1893 contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles, mimicking the response of the cell after natural infection.Read more...

mRNA-1944 Chikungunya Vaccine

mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

mRNA-4157 Cancer Vaccine

mRNA-4157 is a therapeutic vaccine candidate that is a combination of validated defined neoantigens, predicted neoepitopes and mutations in driver genes into a single mRNA concatemer (mRNA-4650).Read more...

MV-CHIK Chikungunya Vaccine

MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...

MV-LASV Lassa Fever Vaccine

MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...

MVA MERS-S Vaccine

MVA-MERS-S (Modified Vaccinia virus Ankara) is a vaccine candidate that contains the full-length spike gene of MERS-CoV.Read more...

MVA-BN WEV Equine Encephalitis Vaccine

MVA-BN WEV is a prophylactic vaccine candidate against three equine encephalitis viruses (western, eastern and Venezuelan.Read more...

MVA-M1+NP Influenza A Vaccine

MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...

MVX-ONCO-1 Cancer Immunotherapy Vaccine

MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...

NanoFlu Influenza Vaccine

NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin (HA) protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...

NanoVax Herpes Simplex Virus Vaccine

NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.Read more...

NasoVAX Influenza Vaccine

NasoVAX is a recombinant intranasal vaccine that is being developed for both seasonal and pandemic use. Read more...

NEO-PV-01 Cancer Vaccine

NEO-PV-01  Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...

NeoVax Cancer Vaccine

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...

New Crown COVID-19 Vaccine

New Crown COVID-19 is an inactivated vaccine that is made of virus particles that are grown in culture and lack disease-producing capability.Read more...

Nexvax2 - Celiac Disease Vaccine

Nexvax2 is a combination of three proprietary peptides that elicit an immune response in patients with celiac disease (CeD) who carry the immune recognition gene, HLA-DQ2.5, which accounts for the condition in 80% to 90% of patients.Read more...

Niprab Nipah Virus Vaccine

Niprab, a pre-clinical vaccine candidate, is a novel recombinant vaccine that uses a modified rabies virus vector and incorporates a gene from Nipah virus Read more...

NOUS-209 Cancer Vaccine

NOUS-209 is an off-the-shelf therapeutic vaccine based on shared tumor neoantigens.Read more...

NVX-CoV2373 SARS-CoV-2 Vaccine

NVX-CoV2372 is a stable, prefusion protein SARS-CoV-2 coronavirus vaccine candidate made using Novavax’ proprietary nanoparticle technology.Read more...

Olumiant Tablet

Olumiant (baricitinib) is an oral, once-daily, JAK1/JAK2 inhibitor, approved in the USA, and 70 other countries as a treatment for adults with moderately to severely active rheumatoid arthritisRead more...

OVX836 Universal Influenza Vaccine

OVX836  is a Universal Influenza Vaccine candidate which targets the NucleoProtein (NP), a highly conserved internal antigen, much less prone to mutations than the traditional surface antigens targeted by current flu vaccines, thus alleviating the need for annual updatesRead more...

Pamvac Malaria Vaccine

Pamvac is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...

Pediarix Vaccine

Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...

PedvaxHIB Haemophilus influenzae type b Vaccine

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

PennVax-GP HIV Vaccine

PennVax-GP has been optimized to target two env antigens, as well as gag and pol antigens. This comprehensive targeting gives PennVax-GP the potential to provide global coverage against HIV-1 subtypesRead more...

Pentacel Vaccine

Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...

PF-04965842 Atopic Dermatitis Vaccine

PF-04965842 is an oral small molecule vaccine candidate that selectively inhibits Janus kinase (JAK) 1.Read more...

PF-06482077 (20vPnC) 20-Valent Pneumococcal Vaccine

PF-06482077 (20vPnC) is a 20-Valent pneumococcal conjugate vaccine candidate to help protect adults from a substantial invasive pneumococcal disease and pneumonia burdenRead more...

PfSPZ-GA1 Malaria Vaccine

PfSPZ-GA1 Malaria Vaccine candidate is a Plasmodium falciparum SPZ vaccine attenuated by the deletion of b9 and slarp. Read more...

PittCoVacc SARS-CoV-2 Vaccine

PittCoVacc SARS-CoV-2 Vaccine uses lab-made pieces of viral protein to build immunityRead more...

Plaquenil Antiviral Medication

Plaquenil (hydroxychloroquine) is used to prevent or treat malaria, and for certain rheumatoid arthritis, systemic lupus erythematosus, and porphyria cutanea trade therapies.Read more...

Pneumococcal Vaccines

Pneumococcal disease is caused by Streptococcus pneumoniae, a bacterium that has more than 90 serotypes. Only a few of these serotypes produce the majority of invasive pneumococcal disease (IPD).

Pneumococcal... Read more...

Pneumovax 23 Pneumococcal Vaccine

Pneumovax 23 vaccine contains 23 serotypes (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F).Read more...

PolyPEPI1018 Colorectal Cancer Vaccine

Description

PolyPEPI1018 an investigational off-the-shelf vaccine for colorectal cancer induced promising immune responses and clinical signs of efficacy when given in combination with standard maintenance therapy in metastatic colorectal cancer... Read more...

Prevnar 13 Pneumococcal Vaccine

Prevnar 13 is a sterile suspension of saccharides of the capsular antigens of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, individually linked to non-toxic diphtheria CRM197 protein. Read more...

Priorix Vaccine

Priorix is a vaccine to protect against measles, mumps, and rubella. Priorix is currently licensed outside the USA in over 100 countries.Read more...

Proquad MMR plus Varicella Vaccine

ProQuad vaccine (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live) is a combined, attenuated, live virus vaccine containing measles, mumps, rubella, and varicella viruses.Read more...

ProscaVax Prostate Cancer Vaccine

ProscaVax vaccine incorporates scientifically proven and clinically validated treatments for cancer.Read more...

Provenge Prostate Cancer Vaccine

Provenge active components are autologous antigen-presenting cells (APCs) and the protein called PAP-GM-CSF.

APCs are activated during a defined culture period with a recombinant human protein, PAP-GM-CSF, consisting of prostatic acid phosphatase (PAP), an antigen expressed in prostate cancer tissue, linked to granulocyte-macrophage colony-stimulating factor (GM‑CSF), an immune cell activator.Read more...

PRV-101 Type 1 Diabetes Vaccine

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.Read more...

PRV-3279 Lupus Vaccine

PRV-3279 is a humanized diabody (a bispecific scaffold biologic molecule) targeting the B-cell surface proteins, CD32B and CD79B, which has the potential to intercept the pathophysiology of systemic lupus erythematosus (SLE) and other B cell-mediated autoimmune diseases.Read more...

Quadracel Diphtheria Vaccine

Quadracel  vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

Quadracel Pertussis Vaccine

Quadracel  vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

Quadracel Polio Vaccine

Quadracel  vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

Quadracel Tetanus Vaccine

Quadracel  vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

RA 27/3 Rubella Vaccine

RA 27/3 rubella vaccine is a live attenuated virus. It was first isolated in 1965 at the Wistar Institute.Read more...

RabAvert Rabies Vaccine

RabAvert is a vaccine that contains an inactivated rabies antigen.Read more...

Recombivax HB Hepatitis B Vaccine

Recombivax HB consists of each 1 mL contains 10 µg hepatitis B surface antigenRead more...

Redeeflu Influenza Vaccine

Redeeflu is a nasal vaccine candidate utilizing a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

REGN-EB3 Ebola

REGN-EB3 is an investigational triple antibody cocktail treatment for Ebola virus infectionRead more...

Remdesivir

Remdesivir is an investigational nucleotide analog with broad-spectrum antiviral activity both in vitro and in vivo models against multiple emerging viral pathogens.Read more...

ResVax RSV Vaccine

ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate. The F protein is essential to RSV infectivity and is the target of palivizumab.Read more...

RH5.1/AS01 Malaria Vaccine

RH5.1/AS01 is a vaccine candidate that make many different types of antibodies against the same RH5 protein target. 

The malaria parasite's protein, RH5, must bind to a human protein on... Read more...

RiVax Ricin Vaccine

RiVax is a safe alum-adjuvanted subunit vaccine candidate which may prevent death and injury from any route of exposure to ricin toxin.Read more...

Rotarix Rotavirus Vaccine

Rotarix is a live, attenuated rotavirus vaccine derived from the human 89-12 strain which belongs to G1P[8] typeRead more...

Rotateq Rotavirus Vaccine

RotaTeq is a live, oral pentavalent vaccine that contains 5 reassortant viruses.Read more...

RSVpreF RSV Vaccine

RSVpreF vaccine candidate is based on the prefusion form of the RSV fusion protein, aided by the discovery of the crystal structure of key viral proteins by the National Institutes of Health.Read more...

RV144 HIV Vaccine

RV144 is an HIV vaccine candidate that combines two different vaccine types: a prime and a booster.Read more...

rVSVN4CT1-EBOVGP1 Ebola Vaccine

rVSVN4CT1-EBOVGP1 is a Monovalent Ebola Zaire Vaccine. Read more...

Sabin IPV Polio Vaccine

Sabin IPV is a liquid trivalent vaccine produced from Sabin poliovirus type 1, 2, and 3 strains grown on Vero cells. Read more...

Sanofi - GSK SARS-CoV-2 Vaccine

Sanofi - GSK SARS-CoV-2 vaccine candidate is a combination of innovative technologies to produce a recombinant protein-based vaccine with an adjuvanted.Read more...

SCB-2019 SARS-CoV-2 Vaccine

http://www.cloverbiopharma.com/index.php?m=content&c=index&a=lists&catid=60SCB-2019 is a recombinant subunit vaccine candidate for SARS-CoV-2 virus that causes COVID-19 disease. Read more...

Sci-B-Vac Hepatitis B Vaccine

Sci-B-Vac is a licensed, third-generation hepatitis B  trivalent vaccine which mimics all three surface antigens, pre-S1, pre-S2, and S, of the hepatitis B virus (“HBV”).Read more...

SCIB1 Cancer Vaccine

SCIB1 is a cancer vaccine candidate that is being developed for the treatment of melanoma.Read more...

scMAYV-E Mayaro Virus Vaccine

scMAYV-E is a novel DNA vaccine that encodes a synthetically-designed consensus MAYV envelope sequence.Read more...

ShigETEC Diarrhea vaccine

ShigETEC vaccine candidate is based on a live, genetically attenuated Shigella vaccine strain able to induce broad protection against shigellosis.Read more...

Shingrix Shingles Vaccine

Shingrix is an adjuvanted recombinant zoster vaccine, consisting of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, and a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...

Simplirix Herpes Simplex Vaccine

Simplirix was a vaccine candidate intended to prevent genital herpes disease in women.Read more...

Sky Zoster Shingles Vaccine

Sky Zoster is a live-attenuated zoster vaccine developed and tested in Korea Read more...

Stamaril Yellow Fever Vaccine

Stamaril is a live, attenuated vaccine that contains the active substance Yellow fever virus 17D-204 strain produced in specified pathogen-free chick embryos.Read more...

SurVaxM Cancer Vaccine

SurVaxM is a peptide mimic immunotherapeutic vaccine (immunotherapy) that targets survivin, a cell-survival protein present in 95 percent of glioblastomas and many other cancers.Read more...

TAK-003 Dengue Vaccine

TAK-003 is a live-attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus. Read more...

TAK-214 Norovirus Vaccine

TAK-214 a vaccine candidate uses virus-like particle (VLP) antigens, which are proteins that precisely mimic the outer surface of norovirus. The vaccine includes antigens from genotypes GI.1 and GII.4, to represent both of the genogroups that cause the majority of human illness.Read more...

TAK-426 Zika Vaccine

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

TetraVax-DV-TV003 Dengue Vaccine

TetraVax-DV-TV003 is a live attenuated recombinant tetravalent dengue vaccine.Read more...

TG4001 HPV Cancer Vaccine

TG4001, previously known as Tipapkinogen Sovacivec, is a vaccine candidate using an attenuated and modified poxvirus (MVA) as a vector expressing the HPV16 E6 and E7 proteins (rendered non-oncogenic) and interleukin-2. Read more...

TG4050 Cancer Vaccine

TG4050 is an individualized therapeutic vaccine designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...

TIV High Dose Influenza Vaccine

UK marketing authorization was granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2Read more...

TLPLDC Melanoma Vaccine

TLPLDC is an autologous therapeutic cancer vaccine that is made from a patient’s own cells and is designed to stimulate the immune system to recognize tumor cells and fight the patient's specific (or unique) cancer.Read more...

TMCP2 Gonorrhea Vaccine

TMCP2 is a vaccine candidate to treat Gonorrhea. It is a complex peptide that is both scalable and economically produced to a high degree of purity.Read more...

Translate Bio mRNA CoV-2 Vaccine

Translate Bio mRNA CoV-2 Vaccine Description

Translate Bio has begun to produce multiple mRNA constructs and will use its mRNA platform to discover, design, and manufacture SARS-CoV-2 vaccine candidates. 

Sanofi will provide... Read more...

Trumenba Meningitis B Vaccine

Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).Read more...

Twinrix Hepatitis A Vaccine

Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].Read more...

Twinrix Hepatitis B Vacccine

Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].Read more...

TY014 Yellow Fever Therapeutic Vaccine

TY014 will be the first therapeutic in the world, specifically targeting Yellow Fever Virus (YFV), to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered to infected cases to reduce disease severity within the patient and their contacts.Read more...

Typbar TCV Typhoid Vaccine

Typbar TCV is a Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine. Read more...

Typhim VI Typhoid Vaccine

Typhim VI is a sterile solution, prepared from the purified polysaccharide capsule of Salmonella typhi (Ty 2 strain).Read more...

UB-311 Alzheimer's Vaccine

UB-311 is fully synthetic and employs the UBITh platform technologies to target aggregated forms of beta-amyloid.Read more...

UQ COVID-19 Vaccine

The University of Queensland COVID-19 vaccine candidate is combined with Seqirus MF59 to improve immune response, reduce the amount of antigen needed for each vaccine, and enable more doses to be manufactured more rapidly.Read more...

V114 Pneumococcal Disease Vaccine

V114 consists of pneumococcal polysaccharides from 15 serotypes conjugated to a CRM197 carrier protein and includes serotypes 22F and 33F, which are commonly associated with invasive pneumococcal disease (IPD) worldwide.Read more...

V180 Dengue Vaccine

V180 is inactivated, containing only the truncated form of the structural envelope protein, which prevents serotypes from interfering with each other.Read more...

Vaqta Hepatitis A Vaccine

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

Varivax Varicella Vaccine

Varivax is a live, attenuated varicella-zoster vaccine, a weakened form of the chickenpox virus.Read more...

Vaxart COVID-19 Oral Vaccine

Vaxart has announced the initiation of a development program to develop an oral H1 flu tablet vaccine targeting the novel SARS-CoV-2 coronavirus.Read more...

Vaxchora Cholera Vaccine

Vaxchora is a live attenuated recombinant V. cholerae O1 Inaba Vaccine Strain CVD 103-HgR, which is able to synthesize the immunogenic nontoxic B subunit of CT (encoded by the ctxB gene).Read more...

Vaxelis Hexavalent Vaccine

Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

VBI-1501 Cytomegalovirus (CMV) Vaccine

VBI-1501 is a vaccine candidate containing a gB antigen which is a major antigen for the induction of neutralizing antibodies against CMV.Read more...

VBI-1901 Glioblastoma (GBM) Cancer Vaccine

VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma, two types of brain tumors.Read more...

VBI-2601 Hepatitis B Vaccine

VBI-2601 is a therapeutic vaccine candidate that targets B- and T-cell immunity through several key mechanisms of actionRead more...

VCL-HB01 Genital Herpes (HSV2) Vaccine

VCL-HB01 is a therapeutic HSV plasmid DNA vaccine candidate formulated with Vaxfectin.Read more...

VGX-3100 HPV Cancer Vaccine

VGX-3100 is an investigational immunotherapy vaccine that includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16 and 18.Read more...

VIR-2703 (ALN-COV)

VIR-2703 is an investigational RNAi therapeutic which will be developed for targeting the SARS-CoV-2 genome for the treatment of Covid-19 (novel coronavirus).Read more...

Vivotif Typhoid Vaccine

Vivotif Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.Read more...

VLA15 Lyme Disease Vaccine

VLA15 is a multivalent Lyme Disease vaccine candidate targeting the outer surface protein A (OspA) of Borrelia. It is designed for prophylactic, active immunization against Lyme disease aiming for protection against the majority of human pathogenic Borrelia species.Read more...

VLA1553 Chikungunya Vaccine

VLA1553 is a monovalent, single dose, live-attenuated Chikungunya vaccine candidate based on an infectious clone (CHIKV LR2006-OPY1) attenuated by deleting a major part of the gene encoding the non-structural replicase complex protein nsP3.Read more...

VLA1601 Zika Vaccine

VLA1601 is a purified, inactivated, whole Zika virus (ZIKV) vaccine candidate adsorbed on aluminum hydroxide (alum).Read more...

VLA2001 SARS-CoV-2 Vaccine

VLA2001 SARS-CoV-2 vaccine leverages Valneva’s well-established platform for IXIARO®, its vaccine approved for active immunization for the prevention of Japanese encephalitisRead more...

VPM1002 Tuberculosis Vaccine

VPM1002  is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...

VRC-ZKADNA090-00-VP Zika Virus Vaccine

VRC-ZKADNA090-00-VP is a Zika virus wildtype DNA vaccine candidate.Read more...

VRC5283 Zika Virus Vaccine

VRC5283 is a Zika Virus DNA Vaccine candidate.  It is composed of a single closed-circular DNA plasmid that encodes with wild type precursor transmembrane M and envelope proteins from the H/PF/2013 strain of ZIKV.Read more...

VXA‑G1.1-NN Norovirus Vaccine

VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...

VXN-319 crKP Vaccine

VXN-319 is a semi-synthetic conjugate early-stage vaccine candidate. Read more...

YF-VAX Yellow Fever Vaccine

YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...

Zabdeno / Mvabea Ebola Vaccine

Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo) is a heterologous prime-boost Ebola vaccine regimen.Read more...

Zika Vaccines

Mosquito transmitted Zika virus has been known for decades, but there are no approved Zika virus vaccines available in the USA today.Read more...

Zostavax Shingles Vaccine

Zostavax is a live, attenuated varicella-zoster virus vaccine.Read more...

ZPIV Zika Vaccine

ZPIV is a Zika virus vaccine candidate which consists of a purified formalin-inactivated Zika virus.Read more...